erythromycin has been researched along with Ritter Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fudaba, Y; Hattori, M; Hirakawa, H; Hisatsune, J; Kato, F; Kayama, S; Oshima, K; Sugai, M; Yamaguchi, T | 1 |
| Johnston, GA; Sladden, MJ | 1 |
1 review(s) available for erythromycin and Ritter Disease
| Article | Year |
|---|---|
Current options for the treatment of impetigo in children.
Topics: Anti-Bacterial Agents; Child; Drug Resistance, Bacterial; Erythromycin; Fusidic Acid; Humans; Impetigo; Infant; Mupirocin; Randomized Controlled Trials as Topic; Staphylococcal Scalded Skin Syndrome; Staphylococcus aureus; Streptococcus pyogenes | 2005 |
1 other study(ies) available for erythromycin and Ritter Disease
| Article | Year |
|---|---|
Emergence of Staphylococcus aureus carrying multiple drug resistance genes on a plasmid encoding exfoliative toxin B.
Topics: Anti-Bacterial Agents; Base Sequence; Dibekacin; Drug Resistance, Multiple, Bacterial; Erythromycin; Exfoliatins; Gentamicins; Humans; Impetigo; Japan; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Retrospective Studies; Staphylococcal Scalded Skin Syndrome; Staphylococcus aureus | 2013 |